Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark (Archives of Osteoporosis, (2020), 15, 1, (81), 10.1007/s11657-020-00746-z)

M. Sanni Ali, Martin Ernst, Danielle E. Robinson, Fergus Caskey, Nigel K. Arden, Yoav Ben-Shlomo, Mads Nybo, Katrine H. Rubin, Andrew Judge, Cyrus Cooper, M. K. Javaid, Anne P. Hermann, Daniel Prieto-Alhambra*

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark (Archives of Osteoporosis, (2020), 15, 1, (81), 10.1007/s11657-020-00746-z)'. Together they form a unique fingerprint.

Medicine & Life Sciences